Sex differences in mortality in stable patients undergoing vasodilator stress cardiovascular magnetic resonance
暂无分享,去创建一个
E. Núñez | J. Núñez | J. Monmeneu | V. Bodí | J. Gavara | F. Chorro | J. Sanchis | G. Miñana | V. Marcos-Garcés | C. Ríos-Navarro | A. Fernández-Cisnal | E. de Dios | A. Fernández‐Cisnal | N. Pérez | M. P. López-Lereu | J. Núñez
[1] V. Fuster,et al. Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.
[2] M. Woodward,et al. Sex Differences in Incident and Recurrent Coronary Events and All-Cause Mortality. , 2020, Journal of the American College of Cardiology.
[3] J. Núñez,et al. Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective Registry. , 2020, JACC. Cardiovascular imaging.
[4] G. Stone,et al. Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease , 2020, Circulation.
[5] Sean M. O'Brien,et al. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. , 2020, JAMA cardiology.
[6] E. Antman,et al. Managing Stable Ischemic Heart Disease. , 2020, The New England journal of medicine.
[7] Sean M. O'Brien,et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. , 2020, The New England journal of medicine.
[8] S. Schulman,et al. Stable ischemic heart disease: how to keep it that way. , 2020, The Journal of clinical investigation.
[9] Christopher J. Rush,et al. Ischemia and No Obstructive Coronary Artery Disease , 2019, Circulation. Cardiovascular interventions.
[10] Susan Cheng,et al. Coronary Microvascular Dysfunction Causing Cardiac Ischemia in Women. , 2019, JAMA.
[11] L. Cho,et al. Unique cardiovascular risk factors in women , 2019, Heart.
[12] D. Mark,et al. Revascularization in stable coronary disease: evidence and uncertainties , 2018, Nature Reviews Cardiology.
[13] M. Eghbali,et al. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy , 2017, Biology of Sex Differences.
[14] V. Lorenzoni,et al. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization. , 2017, JACC. Cardiovascular imaging.
[15] J. Ge,et al. Sex-based influence on clinical outcomes after drug-eluting stent implantation in real-world patients: insight from the FOCUS registry , 2017, Annals of medicine.
[16] P. Libby,et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.
[17] M. Karck,et al. Female Gender and Differences in Outcome after Isolated Coronary Artery Bypass Graft Surgery: Does Age Play a Role? , 2016, PloS one.
[18] Puja K. Mehta,et al. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy , 2015, Nature Reviews Cardiology.
[19] A. Jacobs,et al. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). , 2013, Journal of the American College of Cardiology.
[20] E. Jones,et al. Cardiac syndrome X and microvascular coronary dysfunction. , 2012, Trends in cardiovascular medicine.
[21] R. Blankstein,et al. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. , 2011, JACC. Cardiovascular imaging.
[22] M. Sabatine,et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.
[23] J. Núñez,et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. , 2007, Journal of the American College of Cardiology.
[24] S. Reis,et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. , 2006, Journal of the American College of Cardiology.
[25] Jeroen J. Bax,et al. Magnetic resonance imaging of coronary arteries, the ischemic cascade, and myocardial infarction. , 2005, American heart journal.
[26] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[27] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[28] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.
[29] J. Núñez,et al. Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry. , 2012, Radiology.